Investor mix
4 investors on record; lead investors include Scandinavian Life Science Venture.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 75% |
| Other / undisclosed | 1 | 25% |
Arachidonic acid based drugs for treatment of Asthma, COPD, Rhinitis, Arthritis
4 investors on record; lead investors include Scandinavian Life Science Venture.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 75% |
| Other / undisclosed | 1 | 25% |